Physician

Jignasa J Patel, MD

According to 2025 Medicare claims, Jignasa Patel, MD (NPI: 1710984752) practices internal medicine in the Greenville, NC market, with the plurality of this provider's patient population coming from Pitt, NC. This provider's primary affiliated billing organization is PHYSICIANS EAST, P.A. (NPI: 1598761967; TIN: 561968491) and primary practice location at 27834-5704. Patel is affiliated with the Aledade A4548 NC Legacy MSSP Enhanced (ACO ID: A4548), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 510 traditional Medicare patients, billed 18,302 HCPCS/CPT codes, and received $352,598 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 12,361 prescription claims across 800 beneficiaries totaling $708,922 in drug costs, led by Eliquis (Apixaban). DME data shows 67 claims. Open Payments data shows 2 records totaling $84. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $160,331 to $352,598. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $267,864 to $708,922. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $649 and ending at $2,348.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	338	4,968	$160,331
2016	642	12,019	$254,713
2017	710	19,038	$325,314
2018	666	14,737	$266,437
2019	657	13,176	$250,333
2020	681	15,006	$299,592
2021	684	17,159	$358,595
2022	569	15,894	$349,081
2023	583	18,280	$355,350
2024	510	18,302	$352,598

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	222	4,609	$267,864
2016	427	5,385	$362,315
2017	479	7,634	$503,007
2018	536	8,414	$571,639
2019	535	8,324	$644,372
2020	605	9,161	$675,666
2021	674	10,774	$788,243
2022	685	10,796	$732,557
2023	856	11,669	$780,966
2024	800	12,361	$708,922

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	30	122	$1,303
2016	55	141	$1,477
2017	76	151	$1,227
2018	68	163	$1,605
2019	65	208	$2,911
2020	48	126	$2,973
2021	41	100	$1,275
2022	18	94	$3,373
2023	27	68	$782
2024	16	67	$605

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	385	1,143	$85
84443	Blood test, thyroid stimulating hormone (tsh)	327	397	$16
80061	Blood test, lipids (cholesterol and triglycerides)	325	424	$13
80053	Blood test, comprehensive group of blood chemicals	334	521	$10
36415	Insertion of needle into vein for collection of blood sample	366	887	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	87	4,090	$78,391
Januvia	Sitagliptin Phosphate	64	3,831	$67,071
Ozempic	Semaglutide	55	1,906	$57,931
Arexvy	Rsvpref3 Antigen/As01e/Pf	175	813	$54,269
Linzess	Linaclotide	51	2,520	$42,399

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	16	44	$585
A4259	Lancets, per box of 100	N	N/R	23	$21

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$84	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jignasa J. Patel, MD?

Tedicare shows public-source Medicare data for Jignasa J. Patel, MD (NPI 1710984752), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jignasa J. Patel, MD have ACO affiliation data?

Jignasa J. Patel, MD is shown with ACO affiliation data for Aledade A4548 NC Legacy MSSP Enhanced (MSSP, ACO ID A4548).

What billing organization is linked to Jignasa J. Patel, MD?

Jignasa J. Patel, MD is linked to PHYSICIANS EAST, P.A. (billing NPI 1598761967) in the available physician profile data.

Does Jignasa J. Patel, MD have Open Payments data?

Jignasa J. Patel, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.